# Theranostics Implementation: Opportunities and Challenges

**Authors:** Kunthi Pathmaraj, Andrew M. Scott

PMC · DOI: 10.1055/s-0045-1812103 · World Journal of Nuclear Medicine · 2025-10-07

## Full-text entities

- **Diseases:** neuroblastoma (MESH:D009447), thyroid cancer (MESH:D013964), hyperthyroidism (MESH:D006980), solid (MESH:D018250), neuroendocrine tumors (MESH:D018358), liver cancer (MESH:D006528), cancer (MESH:D009369), paraganglioma (MESH:D010235), hematologic malignancies (MESH:D019337), prostate cancer (MESH:D011471), pheochromocytoma tumors (MESH:D010673), bronchial tumor (MESH:D001984)
- **Chemicals:** 131 I (MESH:C000614965), 131 I-MIBG (MESH:D019797), 177 Lu-DOTATAE (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12602076/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12602076/full.md

---
Source: https://tomesphere.com/paper/PMC12602076